NEU 8.15% $13.27 neuren pharmaceuticals limited

Acadia got Rof Trofenitde AND Global rights for NNZ-2591 for RETT/Fragile X, page-35

  1. 2,047 Posts.
    lightbulb Created with Sketch. 490
    Well Wasa, I think the final outcome of any takeover scenario is still certainly unknown. Things may appear to have swung in Acadia's favour. With NNZ-2591 looking like a very distinct parcel as an asset - it comes with options with regards to the way Neuren might handle it. All those options have been discussed here, but only one them is a takeover by Acadia. That might be wishful thinking by Acadia, or even Neuren, in the meantime, "show us the money" (our money). Having said that, I fully expect that it will arrive in the Neuren coffers before the end of 2023. I guess that's the limit of my test of reasonableness. A lot of interest could be made on that money fwiw.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.27
Change
1.000(8.15%)
Mkt cap ! $1.696B
Open High Low Value Volume
$12.95 $13.39 $12.79 $9.854M 751.2K

Buyers (Bids)

No. Vol. Price($)
3 2545 $13.26
 

Sellers (Offers)

Price($) Vol. No.
$13.29 1443 2
View Market Depth
Last trade - 16.10pm 06/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.